ESC 365 - Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia

ESC Professional Premium Access

Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia

Session: Molecular modifiers of pulmonary vascular disease

Topic: Pharmacotherapy

Speaker: Mr F. Biondi (IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Filippo Biondi

(Italy)

0 follower

7 more presentations in this session

CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study

Speaker: Doctor A. Garcia-Alvarez (Barcelona, ES)

Recruitment of CCR5-positive T cells in pulmonary vascular lesions in idiopathic- and connective tissue disease associated- pulmonary arterial hypertension

Speaker: Doctor K. Ohta-Ogo (Suita, JP)

Comprehensive bioinformatic analysis identified m6A methylation as an important regulator in mediating immune response during idiopathic pulmonary arterial hypertension

Speaker: Doctor N. Liu (Changsha, CN)

Improved prognosis prediction of idiopathic pulmonary arterial hypertension using targeted plasma proteomics in disease management

Speaker: Doctor Y. Yang (Beijing, CN)

PEDF upregulated in Ngfr-positive cells suppresses proliferation of pulmonary artery smooth muscle cells

Speaker: Doctor C. Goten (Kanazawa, JP)

Access the full session

Molecular modifiers of pulmonary vascular disease

Speakers: Mr F. Biondi, Doctor A. Garcia-Alvarez, Doctor K. Ohta-Ogo, Doctor N. Liu, Doctor Y. Yang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources